(株)免疫生物研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証GRT | 医薬品 | 4570/E00986 | Immuno-Biological Laboratories Co.,Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2014/03/14 | 日証協 | 312,000株 | +1.93% | 19,460株 | +22.39% | 226,619株 | +1.25% | 8,700株 | +12.99% |
2014/03/07 | 日証協 | 306,100株 | +2.41% | 15,900株 | -62.17% | 223,829株 | +2.8% | 7,700株 | -11.49% |
2014/02/28 | 日証協 | 298,900株 | +4.77% | 42,030株 | +151.08% | 217,729株 | +2.88% | 8,700株 | -12.12% |
2014/02/21 | 日証協 | 285,300株 | +1.93% | 16,740株 | -12.36% | 211,629株 | +0.28% | 9,900株 | -19.51% |
2014/02/14 | 日証協 | 279,900株 | +10.2% | 19,100株 | -54.2% | 211,029株 | +2.28% | 12,300株 | -52.73% |
2014/02/07 | 日証協 | 254,000株 | -6.62% | 41,700株 | +35.83% | 206,329株 | +0.1% | 26,020株 | +26.88% |
2014/01/31 | 日証協 | 272,000株 | +10.93% | 30,700株 | +91.88% | 206,116株 | +6.89% | 20,507株 | +272.85% |
2014/01/24 | 日証協 | 245,200株 | +3.2% | 16,000株 | +187.77% | 192,834株 | +2.61% | 5,500株 | +103.7% |
2014/01/17 | 日証協 | 237,600株 | +1.02% | 5,560株 | +2680% | 187,934株 | -0.74% | 2,700株 | -18.45% |
2014/01/10 | 日証協 | 235,200株 | -0.17% | 200株 | 0% | 189,334株 | +4.13% | 3,311株 | +106.94% |
2013/12/30 | 日証協 | 235,600株 | +0.26% | 0株 | -100% | 181,823株 | +0.17% | 1,600株 | -80.98% |
2013/12/27 | 日証協 | 235,000株 | +0.34% | 4,170株 | +421.25% | 181,523株 | -4.62% | 8,410株 | +31% |
2013/12/20 | 日証協 | 234,200株 | -1.43% | 800株 | 0% | 190,313株 | +1.83% | 6,420株 | +668.86% |
2013/12/13 | 日証協 | 237,600株 | 0% | 800株 | 0% | 186,893株 | -0.09% | 835株 | -89.43% |
2013/12/06 | 日証協 | 237,600株 | 0% | 0株 | -100% | 187,068株 | +2.37% | 7,900株 | +364.71% |
2013/11/29 | 日証協 | 237,600株 | -10.81% | 5,800株 | 0% | 182,733株 | -7.16% | 1,700株 | +108.33% |
2013/11/22 | 日証協 | 266,400株 | -0.15% | 0株 | -100% | 196,833株 | +0.11% | 816株 | -88.67% |
2013/11/15 | 日証協 | 266,800株 | +2.5% | 6,200株 | +93.75% | 196,617株 | +4.13% | 7,200株 | +38.46% |
2013/11/08 | 日証協 | 260,300株 | +0.42% | 3,200株 | +433.33% | 188,817株 | +1.23% | 5,200株 | -18.8% |
※株式分割は考慮していませんのでご注意ください。